Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VacV Biotherapeutics logo — Developing oncolytic viruses as therapeutics for cancer

VacV Biotherapeutics

Developing oncolytic viruses as therapeutics for cancer

Founded 2022 United Kingdom London, United Kingdom 6 employees Seed Total: $3.00M Biotechnology, Health Care +1

General Information

Company Name VacV Biotherapeutics
Founded Year 2022
Location United Kingdom London, United Kingdom +1
Employees 6
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Social

Get notified when VacV Biotherapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VacV Biotherapeutics

VacV Biotherapeutics, with the slogan "Developing oncolytic viruses as therapeutics for cancer," is a UK-based startup founded in 2022. The company, led by cancer immunotherapy experts Professor Yaohe Wang, Professor Nicholas Lemoine, Dr. Louisa Chard Dunmall, and Dr. Peng Liu, is focused on developing innovative viral-based therapies for cancers. Their unique approach is based on the Vaccinia virus, which aims to stimulate a patient’s immune system to fight cancer while simultaneously destroying cancer cells. This cutting-edge approach offers advantages over existing immunotherapies, including minimized toxicity, higher specificity, and efficacy, allowing for efficient systemic delivery of an immunotherapy for the first time. VacV Biotherapeutics recently secured a $3.00M Seed Round investment on 01 January 2022 led by Proxima Ventures. The startup operates in the biotechnology, health care, and life sciences industries.

Taxonomy: biotech, cancer immunotherapy, oncolytic virus, viral-based therapy, tumor-specificity, neurotoxicity, therapeutic potential, EEV production, biopharmaceuticals, treatment innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
01 Jan 2022

VacV Biotherapeutics Alternatives & Competitors

VacV Biotherapeutics vs
Caedo Oncology AS
Caedo Oncology AS Norway

We create improved treatment options for cancer patients through unique immunotherapy opportunities

Series Unknown
6 employees
Biotechnology, Health Care
VacV Biotherapeutics vs
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics United States

KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer trea...

Series A
43 employees
Health Care, Health and Wellness
Compare VacV Biotherapeutics vs KaliVir Immunotherapeutics
VacV Biotherapeutics vs
Ankyra Therapeutics
Ankyra Therapeutics

Developing cancer therapies based on localized cytokines that prime a systemic adaptive immune respo...

Series B
23 employees
Biotechnology

FAQ About VacV Biotherapeutics

Developing oncolytic viruses as therapeutics for cancer
VacV Biotherapeutics was founded in 2022.
VacV Biotherapeutics is headquartered in London, United Kingdom.
VacV Biotherapeutics operates in the following industries: Biotechnology, Health Care, Life Sciences.
VacV Biotherapeutics has approximately 6 employees.
VacV Biotherapeutics has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Seed.
Top alternatives and competitors to VacV Biotherapeutics include Caedo Oncology AS, KaliVir Immunotherapeutics, Ankyra Therapeutics, Dr Krishna's Cancer Healer Center, Aethon Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VacV Biotherapeutics and Caedo Oncology AS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VacV Biotherapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes